Subscribe to RSS
DOI: 10.1055/s-2006-950432
The First Examples of Planar Chiral Organic Benzimidazole Derivatives
Publication History
Publication Date:
22 September 2006 (online)
Abstract
The synthesis of a number of novel planar chiral benzimidazoles from [2.2]paracyclophane is reported. The key steps include a Buchwald-Hartwig amination of a sterically demanding triflate and the functionalisation of the C-2 bromide.
Key words
planar chirality - heterocycles - cyclophanes - amination
- 1
Nakano H.Inoue T.Kawasaki N.Miyataka H.Matsumoto H.Taguchi T.Inagaki N.Nagai H.Satoh T. Bioorg. Med. Chem. 2000, 8: 373 - 2
Zhu ZJ.Lippa B.Drach JC.Townsend LB. J. Med. Chem. 2000, 43: 2430 - 3
Chua MS.Shi DF.Wrigley S.Bradshaw TD.Hutchinson I.Shaw PN.Barrett DA.Stanley LA.Stevens MFG. J. Med. Chem. 1999, 42: 381 - 4
Terauchi H.Tanitame A.Tada K.Nakamura K.Seto Y.Nishikawa Y. J. Med. Chem. 1997, 40: 313 -
5a
Harkal S.Rataboul F.Zapf A.Fuhrmann C.Riermeier T.Monsees A.Beller M. Adv. Synth. Catal. 2004, 346: 1742 -
5b
Shavaleev NM.Bell ZR.Easun TL.Rutkaite R.Swanson L.Ward MD. Dalton Trans. 2004, 3678 -
5c
Stibrany RT.Lobanov MV.Schugar HJ.Potenza JA. Inorg. Chem. 2004, 43: 1472 -
5d
Figge A.Altenbach HJ.Brauer DJ.Tielmann P. Tetrahedron: Asymmetry 2002, 13: 137 -
6a
Hadei N.Kantchev EAB.O" Brien CJ.Organ MG. Org. Lett. 2005, 7: 1991 -
6b
Page PCB.Buckley BR.Christie SDR.Edgar M.Poulton AM.Elsegood MRJ.McKee V. J. Organomet. Chem. 2005, 690: 6210 - 7
Orlandi S.Caporale M.Benaglia M.Annunziata R. Tetrahedron: Asymmetry 2003, 14: 3827 - 8
Murphy JA.Khan TA.Zhou SZ.Thomson DW.Mahesh M. Angew. Chem. Int. Ed. 2005, 44: 1356 - 9
Nomura M.Shibasaki Y.Ueda M.Tugita K.Ichikawa M.Taniguchi Y. Synth. Met. 2005, 151: 261 -
10a
Modern Cyclophane Chemistry
Gleiter R.Hopf H. Wiley-VCH; Weinheim: 2004. -
10b
Vögtle F. Cyclophane Chemistry Wiley; Chichester: 1993. - 11
Morisaki Y.Chujo Y. Bull. Chem. Soc. Jpn. 2005, 78: 288 - 12
Bartholomew GP.Rumi M.Pond SJK.Perry JW.Tretiak S.Bazan GC. J. Am. Chem. Soc. 2004, 126: 11529 - 13
Gibson SE.Knight JD. Org. Biomol. Chem. 2003, 1: 1256 - 14
Rozenberg V.Sergeeva E.Hopf H. In Modern Cyclophane ChemistryGleiter R.Hopf H. Wiley-VCH; Weinheim: 2004. -
15a
Löber S.Ortner B.Bettinetti L.Hübner H.Gmeiner P. Tetrahedron: Asymmetry 2002, 13: 2303 -
15b
Ortner B.Hübner H.Gmeiner P. Tetrahedron: Asymmetry 2001, 12: 3205 -
15c
Ortner B.Waibel R.Gmeiner P. Angew. Chem. Int. Ed. 2001, 40: 1283 - 16
Yanada R.Higashikawa M.Miwa Y.Taga T.Yoneda F. Tetrahedron: Asymmetry 1992, 3: 1387 - 17
Hitchcock PB.Parmar R.Rowlands GJ. Chem. Commun. 2005, 4219 -
18a
Hitchcock PB.Rowlands GJ.Seacome RJ. Org. Biomol. Chem. 2005, 3: 3873 -
18b
Rowlands, G. J.; Seacome, R. J. Tetrahedron Lett., submitted
-
19a
Bolm C.Wenz K.Raabe G. J. Organomet. Chem. 2002, 662: 23 -
19b
Hou XL.Wu XW.Dai LX.Cao BX.Sun J. Chem. Commun. 2000, 1195 - 20
Pelter A.Mootoo B.Maxwell A.Reid A. Tetrahedron Lett. 2001, 42: 8391 - 21
Kreis M.Nieger M.Bräse S. J. Organomet. Chem. 2006, 691: 2171 - 22
Hopf H.Barrett DG. Liebigs Ann. Chem. 1995, 449 - 23
Wolfe JP.Wagaw S.Marcoux JF.Buchwald SL. Acc. Chem. Res. 1998, 31: 805 - 24
Gotteland JP.Halazy S. Synlett 1995, 931 -
25a
Bondarenko L.Dix I.Hinrichs H.Hopf H. Synthesis 2004, 2751 -
25b
Braddock DC.MacGilp LD.Perry BG. J. Org. Chem. 2002, 67: 8679 -
25c
Kreis M.Bräse S. Adv. Synth. Catal. 2005, 347: 313 - 26
Kreis M.Friedmann CJ.Bräse S. Chem. Eur. J. 2005, 11: 7387 - 27
Rossen K.Pye PJ.Maliakal A.Volante RP. J. Org. Chem. 1997, 62: 6462 - 28
Wolfe JP.Buchwald SL. J. Org. Chem. 2000, 65: 1144
References and Notes
4-(4-Methoxyphenylamino)[2.2]paracyclophan-5-yl Carboxylic Acid Methyl Ester (8); Typical Procedure: A solution of triflate 7 (4.00 g, 9.66 mmol) in toluene (20 mL) was added dropwise over 1 h to a mixture of p-anisidine (1.46 g, 11.59 mmol), tris(dibenzylideneacetone)dipalla-dium(0) (0.44 g, 0.48 mmol), (±)-BINAP (0.45 g, 0.72 mmol) and Cs2CO3 (4.31 g, 13.23 mmol) in toluene (10 mL) at reflux. The mixture was stirred at this temperature for a further 12 h. The reaction was cooled to r.t., filtered through celite and concentrated. The crude product was purified by flash column chromatography (4% Et2O-PE → 8% Et2O-PE) to afford 8 as a bright yellow crystalline solid (2.90 g, 78%); mp 174-176 °C. IR (CHCl3): 3336, 2947, 1680, 1574, 1514, 1461, 1439, 1415, 1240 cm-1. 1H NMR (300 MHz, CDCl3): δ = 8.61 (1 H, s, NH), 7.04 (1 H, dd, J = 7.8, 1.8 Hz, H-15 or H-16), 6.88 (2 H, d, J = 8.4 Hz, MeOAr-H), 6.78 (2 H, d, J = 8.4 Hz, MeOAr-H), 6.61 (1 H, dd, J = 7.8, 1.5 Hz, H-15 or H-16), 6.52-6.45 (3 H, m, H-12, H-13 and H-7 or H-8), 6.39 (1 H, d, J = 7.8 Hz, H-7 or H-8), 3.85 (3 H, s, OMe), 3.71 (3 H, s, OMe), 3.63 (1 H, ddd, J = 12.6, 9.6, 2.4 Hz, H-9), 3.12 (1 H, ddd, J = 12.0, 9.6, 2.1 Hz, H-10), 2.97-2.61 (5 H, m, 5 × CH2), 2.59-2.45 (1 H, m, CH2). 13C NMR (75 MHz, CDCl3): δ = 170.3 (C=O), 154.8 (C), 144.0 (CH), 142.1 (C), 139.9 (C), 139.5 (CH), 138.7 (C), 137.6 (C), 133.5 (C), 133.4 (CH), 132.1 (CH), 130.9 (CH), 129.5 (CH), 127.8 (CH), 121.5 (C), 118.9 (CH), 114.8 (CH), 56.1 (CH3), 52.2 (CH3), 36.6 (CH2), 35.3 (CH2), 35.3 (CH2), 34.3 (CH2). MS (EI): m/z = 387 [M]+, 355, 354 [M - CH3OH]+, 283, 268, 251, 236, 220, 208, 192. HRMS (EI): m/z calcd for C25H25NO3 (MH+): 388.1907; found: 388.1905.
302-Bromo-3-(4-methoxyphenylamino)[2.2](4,7)benzimida-zoloparacyclophane (14); Typical Procedure: A solution of 11 (0.41 g, 1.12 mmol) and phosphorus(V) oxybromide (0.80 g, 2.80 mmol) in toluene (16 mL) was heated to reflux for 5 h. The reaction mixture was cooled to r.t. and washed with a sat. aq soln of NaHCO3 (25 mL). The organic layer was separated and the aq layer extracted with CH2Cl2 (3 × 20 mL). The combined extracts were filtered to remove any insoluble impurities, dried (MgSO4), concentrated and purified by flash column chromatography (10% heptane-Et2O→ 20% heptane-Et2O) to afford 14 as a white crystalline solid (0.41 g, 85%); mp 156-159 °C. IR (CHCl3): 3010, 2959, 2932, 2954, 1609, 1585, 1511, 1456, 1300, 1253, 1169 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.65 (1 H, dd, J = 8.7, 2.4 Hz, H-2 or H-6 of MeOC6H4), 7.08 (1 H, dd, J = 8.7, 2.7 Hz, H-2 or H-6 of MeOC6H4), 7.02 (1 H, dd, J = 8.7, 2.4 Hz, H-3 or H-4 of MeOC6H4), 6.90 (1 H, dd, J = 8.7, 3.0 Hz, H-3 or H-4 of MeOC6H4), 6.51 (1 H, d, J = 7.5 Hz, H-5 or H-6), 6.39-6.41 (2 H, m, H-5 or H-6 and pseudo-p N-1 or pseudo-p N-3), 6.28 (1 H, dd, J = 7.8, 1.5 Hz, pseudo-p N-1 or pseudo-p N-3), 6.22 (1 H, dd, J = 7.8, 1.8 Hz, pseudo-gem N-1 or pseudo-gem N-3), 6.05 (1 H, dd, J = 7.8, 1.8 Hz, pseudo-gem N-1 or pseudo-gem N-3), 3.84 (3 H, s, OMe), 3.67-3.75 [1 H, m, (C-7)-CH2], 3.03 [1 H, ddd, J = 14.4, 12.3, 4.2 Hz, (C-7)-CH2CH2], 2.96-2.71 (2 H, m, CH2), 2.53-2.37 (1 H, m, CH2), 2.11 [1 H, ddd, J = 12.9, 9.6, 7.2 Hz, (C-4)-CH2]. 13C NMR (75 MHz, CDCl3): δ = 160.3 (C), 145.4 (C), 139.3 (C), 138.1 (C), 138.0 (C), 133.0 (CH), 132.0 (C), 131.8 (CH), 131.3 (CH), 129.7 (C), 129.6 (C), 129.5 (CH), 129.3 (C), 129.0 (CH), 128.7 (CH), 127.1 (CH), 125.4 (CH), 125.1 (C), 115.1 (CH), 114.7 (CH), 56.1 (CH3), 35.4 (CH2), 34.9 (CH2), 31.9 (CH2), 30.8 (CH2). MS (EI): m/z = 435 [81M]+, 433 [79M]+, 330, 328, 297, 299, 249, 205. HRMS (EI): m/z calcd for C24H21N2OBr (79MH+): 433.0910; found: 433.0903.
31CCDC 611020 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at www.ccdc.cam.ac.uk/conts.retrieving.html [or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 (1223)336033; e-mail: deposit@ccdc.cam.ac.uk].
32CCDC 611019 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at www.ccdc.cam.ac.uk/conts.retrieving.html [or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 (1223)336033; e-mail: deposit@ccdc.cam.ac.uk].